Endpoints News
Inside Anthropic's sprint into biotech Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M Tue W Th F
21 July, 2026
THE BANK THAT TAKES YOU FROM SEED STAGE TO WORLD STAGE
J.P. Morgan was the right banking team for Montara Therapeutics. Founder Nicholas Hertz trusted the team’s life sciences expertise, security, and support to focus on what mattered most.
sponsored by J.P.Morgan
presented by Viiv Healthcare
HIV Ends Here: In­side Vi­iV Health­care’s Sin­gu­lar Mis­sion
news
Exclusive: A David Baker spinout launches AI antibody data consortium with GSK, Boltz and others
ENDPOINTS NEWS
Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambition
ENDPOINTS NEWS
House lawmakers rally behind trade probe of China biotech market
ENDPOINTS NEWS
Endpoints webinars
Jul 30
1:00 pm ET
Accelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights
GUARDANT
Aug 19
1:00 pm ET
From pilots to production: AI across R&D, safety, regulatory, and clinical
IBM
Endpoints Careers
Associate Director / Director, Preclinial Development - Immunology
Terray Therapeutics, Inc.
Monrovia, CA, USA
Senior Director, Licensing Officer
Bayer
Cambridge, MA, USA
Recruit talent with Endpoints Careers
Contact Meg Estacio: mestacio@endpointsnews.com
Endpoints 11 - Reserve Your Spot
The most differentiated science stays out of public view. This September, the Endpoints newsroom reveals the 11 private companies worth watching, live at the State Room in Boston. See the list first, reserve your spot and save with the early bird rate.
in case you missed it
1.
J&J, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal
ENDPOINTS NEWS
2.
Bristol Myers says it will build pharma's 'most powerful' AI supercomputer with Nvidia
ENDPOINTS NEWS
3.
Samsung Bio to expand its wheelhouse in $1.8B buy for peptide API maker
ENDPOINTS NEWS
4.
UK biotech VC funding rebounds and reaches record high
ENDPOINTS NEWS
5.
News Briefing
Scribe's $96M IPO; Scholar Rock awaits site classification for apitegromab
ENDPOINTS NEWS
6.
Cancer drug approvals in China outpace those in US, study finds
BLOOMBERG
Reynald Castaneda
.

Andrew Dunn has been busy covering the steady flow of AI stories in biopharma. Today, he writes about the launch of a startup that offers a quarterly subscription to consortium data to improve the output of pharma's AI models. Check out the story here.

.
Reynald Castaneda
Deputy Editor, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: